Most Recent Episode
Drugs.com - Monthly Update January 2026 This month discover the latest approval for Darzalex Faspro in newly diagnosed multiple myeloma. Learn about a new presbyopia treatment called Yuvezzi; Zycubo, the first treatment for Menkes disease in children; and the latest on the extended use of the
Time: 5:32
In our latest episode, we cover the latest approval of Darzalex Faspro for multiple myeloma, age-related near vision loss, and a rare genetic disorder affecting children. We also discuss an extension to the use of Nexplanon, a long-acting birth control, and a simpler transition for those moving from injected to inhaled insulin.
Darzalex Faspro (daratumumab and hyaluronidase-fihj) a new approval for use in combination with standard treatments for adults with newly diagnosed multiple myeloma.Yuvezzi (carbachol and brimonidine tartrate), a novel combination eye drop for presbyopia.Zycubo (copper histidinate), the first treatment for Menkes disease in children.Nexplanon (etonogestrel), a birth control implant with an extension of use for up to five years.Afrezza (insulin human), an inhaled insulin, with updated dosing guidance.Chapters
(00:00) - Intro
(00:21) - Overview
(00:47) - Darzalex
(02:13) - Yuvezzi
(03:06) - Zycubo
(03:50) - Nexplanon
(04:35) - Afrezza
(05:09) - Outro
Follow Drugs.com:X, Facebook, YoutubeSignup to our newslettersDownload the app
GUID: fd49b543-4761-4fcd-b28f-d0c148b1b6c5
Release Date: 02/02/2026, 06:28:00
